Heal Park Clinics

Dr. Silambarasan Maskomani

  • Specialties:Clinical Genomicist | Precision Oncology Specialist
  • Experience:10+
  • Phone:
  • Email:

Dr. Silambarasan Maskomani

Clinical Genomicist | Precision Oncology Specialist | ESMO Member

Dr. Silambarasan Maskomani, PhD, is a distinguished Clinical Genomicist and Precision Oncology Specialist known for integrating advanced genomic science with compassionate cancer care. With over a decade of experience, he focuses on delivering individualized treatment strategies that ensure patients receive the right therapy at the right time. His philosophy blends scientific rigor with empathy, making him a trusted expert in personalized cancer medicine.

  • PhD in Clinical Genomics / Molecular Oncology

  • Gold Medalist in undergraduate studies

  • University Rank Holder in postgraduate studies

  • Selected as Pioneer Molecular Scientist at

    • Yong Loo Lin School of Medicine, National University of Singapore (NUS)

    • National University Health System (NUHS), Singapore

  • Advanced training at MD Anderson Cancer Center, USA

  • ESMO Member (European Society for Medical Oncology)

  • Molecular Oncology

  • Precision Oncology

  • Comprehensive Genomic Profiling

  • Liquid Biopsy Technologies

  • Solid Tumors & Hematologic Malignancies

  • Immuno-oncology Biomarkers

  • Translational Cancer Genomics

  • Personalized Therapy Planning

  • Over 10 years of experience in molecular and precision oncology

  • Instrumental in introducing:

    • Advanced genomic testing

    • Comprehensive cancer profiling

    • Liquid biopsy solutions for diagnosis, treatment selection, and monitoring

  • Experience working with globally renowned cancer centers and biomedical institutions

  • Active contributor to enhancing clinical decision-making through evidence-based genomic insights

  • Multiple national awards for contributions to molecular diagnostics in India

  • Invited speaker, moderator, and expert panelist at national and international oncology conferences

  • Recognized for delivering high-impact scientific sessions blending clinical expertise and molecular science

  • Esteemed for leadership and innovation in precision-driven cancer care